Exelixis Stock News

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

EXEL vs. TECH: Which Stock Is the Better Value Option?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Among biotech stocks, there are several established names that have products in markets and deep pipelines. These companies deliver predictable revenue and earnings, and maybe even a dividend for good

Learn more about an opportunity to acquire well-known big-cap names in the S&P 500 that, at this point, could provide "tech-like" returns.

Regulatory and pipeline updates from ICPT and KALV are the key highlights from the biotech sector during the past week.

These top-tier companies are begging to be bought following a 34% peak decline in the Nasdaq Composite.

These top-tier companies are begging to be bought following a 34% peak decline in the Nasdaq Composite.

These drugmakers seem to have a knack for innovation.

If one can bear the risk with these stocks, the rewards can be extraordinary.

These companies are small now. But they have massive long-term growth prospects.

These companies are small now. But they have massive long-term growth prospects.

Biotech stocks have performed relatively well compared to the broader market of late. The SPDR S&P Biotech ETF (NYSEARCA: XBI ) is up 21% over the past three months compared with a 6% gain for the S&P

I've written before about how biotech is the biggest technology trend of our kids' generation. Naturally, that means many people are looking for the best biotech stocks to buy.

Just don't be too quick to press the buy button.